Veterinary Medicines

Prednisolon ad us. vet 10 mg/ml suspension for injection for cattle, horses, dogs and cats

Authorised
  • Prednisolone acetate
Download as PDF

Product identification

Medicine name:
Prednisolon ad us. vet 10 mg/ml suspension for injection for cattle, horses, dogs and cats
Cortico Veyxin 10 mg/ml suspensija injekcijām liellopiem, zirgiem, suņiem un kaķiem
Active substance:
  • Prednisolone acetate
Target species:
  • Cattle
  • Dog
  • Horse
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Prednisolone acetate
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        35
        day
      • Milk
        24
        hour
    • Dog
    • Horse
      • Meat and offal
        53
        day
      • Milk
        no withdrawal period
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • (ID3) 1200 millilitre(s): unspecified outer container with 12 Vial (Glass) each with 100 millilitre(s)
  • (ID2) 600 millilitre(s): unspecified outer container with 6 Vial (Glass) each with 100 millilitre(s)
  • (ID1) 100 millilitre(s): unspecified outer container with 1 Vial (Glass) with 100 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/18/0046
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0162/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download
Latvian (PDF)
Published on: 10/04/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/04/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/04/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."